Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Gary Tanner, a former executive at Valeant Pharmaceuticals, and Andrew Davenport, the former CEO of Philidor Rx Services, for engaging in a multimillion-dollar kickback scheme.
read more
Patheon has announced the appointment of Gilles Cottier as president of the company’s pharmaceutical development services (PDS) division effective immediately. He will serve as a member of Patheon’s executive committee and will report to Patheon CEO ...
read more
Charles River Laboratories has appointed former FDA Principal Deputy Commissioner Namandjé N. Bumpus, Ph.D., to chair its newly established Scientific Advisory Board, guiding the company’s strategy to advance New Approach Methodologies (NAMs) that ...
read more
Monday, September 18, 2017
NeuroCog Trials announced the addition of former AIFA Director General, Dr. Luca Pani, as Executive Director of Global Medical Innovation.
read more
Formedix has announced the expansion of its development and test teams.
read more
Formedix, a leading provider of clinical trial software solutions, has collaborated with CDISC, the global clinical research data standards development organization, to create a novel portal providing free access to ready-to-use, CDASH-compliant, ...
read more
FORMA Therapeutics and Arpeggio Biosciences announced a collaboration to utilize Arpeggio Biosciences’ proprietary technology to supplement FORMA’s analysis of the biological effects of its potential drug candidates.
read more
Wednesday, March 04, 2026
Forma Life Sciences announced its launch as an independent, operator-owned contract development and manufacturing organization (CDMO) focused on oral solid dosage formulation development, clinical manufacturing, and commercial drug product ...
read more
Forge Biologics, a gene therapy-focused contract development and manufacturing organization (CDMO), announced the appointment of John Maslowski to the newly created role of Chief Commercial Officer. Mr. Maslowski brings significant gene therapy ...
read more
Thursday, January 26, 2023
Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced the addition of three key leadership hires to further the Company’s growth as a leading manufacturer of genetic medicines.
read more
In a strategic new alignment, Van Heron Labs, a startup formed in Houston, will begin working alongside Huntsville’s Foresight Biosciences.
read more
Wednesday, September 20, 2017
Foreign Secretary Boris Johnson has officially opened TraceLink’s new European headquarters in Uxbridge, UK.
read more
In a year when the Food and Drug Administration (FDA) has made highly publicized moves to emphasize driving data in sleep dosage recommendations and labeling issues, Cognitive Research Corporation (CRC, www.cogres.com) offers pharmaceutical companies...
read more
Wednesday, October 23, 2019
Foamix has entered into a long term contract manufacturing and supply agreement with ASM for AMZEEQ™ topical foam, 4%.
read more
Foamix, together with LEO, has entered into a settlement and license agreement with an affiliate of Teva to resolve pending patent litigation involving Finacea® Foam.
read more